Literature DB >> 21637444

Three novel polymorphic microsatellite markers for the glaucoma locus GLC1B by datamining tetranucleotide repeats on chromosome 2p12-q12.

Carlos Murga-Zamalloa1, Maria Luisa Guevara-Fujita, Alejandro Estrada-Cuzcano, Ricardo Fujita.   

Abstract

In order to identify new markers around the glaucoma locus GLC1B as a tool to refine its critical region at 2p11.2-2q11.2, we searched the critical region sequence obtained from the UCSC database for tetranucleotide (GATA)n and (GTCT)n repeats of at least 10 units in length. Three out of four potential microsatellite loci were found to be polymorphic, heterozygosity ranging from 64.56% to 79.59%. The identified markers are useful not only for GLC1B locus but also for the study of other disease loci at 2p11.2-2q11.2, a region with scarcity of microsatellite markers.

Entities:  

Keywords:  GLC1B; gene mapping; glaucoma; microsatellite polymorphic markers; tetranucleotide tandem repeat

Year:  2009        PMID: 21637444      PMCID: PMC3036884          DOI: 10.1590/S1415-47572009005000093

Source DB:  PubMed          Journal:  Genet Mol Biol        ISSN: 1415-4757            Impact factor:   1.771


Primary open angle glaucoma (POAG), an optic neuropathy, is one of the leading causes of blindness (prevalence 3-7% worldwide), although early detection makes it preventable (Wolfs ). POAG heritability is high and family studies revealed at least eight loci with only two causative genes identified so far (Challa, 2004). Locus GLC1B was mapped by linkage analysis in British families to a region of about 21 Mb flanked by markers D2S176 and D2S2161 on chromosome 2cen-q13 (Stoilova ). We reported a Peruvian family with POAG linked to the GLC1B region, with an unaffected member presenting the same haplotype as affected relatives, regarding markers D2S2264, D2S1897and D2S176, but not sharing the alleles at D2S417 and D2S2161 (Fujita ; Guevara-Fujita ). The segment delimited by D2S176 and D2S2264 was discarded for GLC1B, thus narrowing down the locus critical region to about 15,5 Mb (Fig 1). In order to refine the location of GLC1B, we sought markers between D2S2264 and D2S417 which were about 15 Mb apart. However, the reported microsatellite markers did not evenly cover this region, neither were informative in the family we were studying. This prompted us to search for tetranucleotide repeat markers in the GLC1B region, since it is well recognized that tetranucleotide motifs present better allele separation and extra bands than dinucleotide. We searched the NCBI HUMAN GENOME DATASE for these motifs mapping at the segment of about 16 Mb between markers D2S417 and D2S2264 at 2p11.2-2q11.2. Primers flanking candidate markers were designed and their heterozygosity tested in healthy non-related individuals and in our previously reported POAG family. (Fujita 2002, Guevara-Fujita ). DNA was obtained from peripheral blood of a total of 106 healthy non-related volunteers using routine salting-out method. Sequences from 2p11.2 and 2q11.2 (between D2S417 and D2S2264) from NCBI BUILD 36.1 available from ‘The Human Genome Browser at UCSC' Genomic Library were searched for tetranucleotide repeats with (GATA)n motifs at least 10 units long their flanking sequences, using BIOEDIT SEQUENCE ALIGNMENT EDITOR® software. Selected sequences were analyzed using VECTOR NTI 8® (Demo version) for primer design calculations. Reactions were performed in a volume of 10 μL, containing 50 ng of DNA, 2.5 mM each of dNTPs, 1 mM of each primer, 1 unit of Taq polymerase and 1 μL of 10X buffer with 1 μL of 10X MgCl2. PCR products were amplified on an Amplitron II Thermolyne thermocycler cycling conditions: 35 cycles of 94 °C for 30 s, optimal annealing temperature for 30 s and 72 °C for 30 s. PCR products were electrophoresed on 5 or 6% denaturing acrylamide gels, alleles subsequently revealed by silver staining. Allele sizes were determined by comparison with a pUC18 sequencing reaction product. Four sequences with a (GATA)n motif were identified on the 15,5 Mb segment between 2p11.2 and 2q11.2. To assess heterozygosity, 106 individuals (212 chromosomes) were genotyped from a sample of Lima population, a heterogeneous admixture of South American native and Caucasian ancestries, with minor Asian and African contributions. Three of the identified loci turned out to be polymorphic (Table 1). Figure 1 shows the relative location of the new markers D2SCATTO3, D2SCATTO4, D2SCATTO2 and D2SCATTO1 and of the reference markers between D2S216 and D2S176 on the GLC1B locus region on chromosome 2. Table 1 also shows the optimal annealing temperature, allele frequencies, allele size and heterozygosity calculated for each new marker. Marker D2SCATTO1 showed eight alleles ranging from 244 to 272 base pairs (bp) with heterozygosity of 75.15%, marker D2SCATTO2 eight alleles ranging from 319 to 347 bp with heterozygosity of 79.59%, and marker D2SCATTO3 three alleles ranging from 221 to 229 bp with heterozygosity of 64.56%. At D2SCATTO4 only one 291 bp product was obtained in the sample analyzed. Allele sizes of three of the new polymorphic markers allow for multi-loading, making genotyping easier and reducing lab work and time. Primer sequences, cytogenetic localization and allele sizes of each marker are deposited in the NCBI dbSNP (BUILD B131, D2SCATTO1 NCBI ss: 142466905; D2SCATTO2 NCBI ss: 142466907; D2SCATTO3 NCBI ss: 14246691; 2D2SCATTO4 NCBI ss:142466910).
Table 1

Markers identifed in the present study, genomic location, allele sizes and frequencies, and primer sequences.

MarkersCytogenetic locationPrimers
Annealing temperatureAlleles (bp)Frequency
ForwardReverse
D2SCATTO32p11.2 (Chr2: 89399095-89399314 Mb)GGTCCAATTCCCTGGAACCACCAGGCCAGATAGCCAGTGGCAGGACC62 °C2210.25
2250.45
2290.30

D2SCATTO42q11.2 (Chr2: 97104768-97105061 Mb)GCACCAGGCTCTATCCTGCACCGGGTTTCAGCTGTTTGTAACAGCC60 °C2641.00

D2SCATTO22q11.2 (Chr2: 99437128-99437461 Mb)TGTACTCCCTCTCCGGGGATCGGGCCATACTGTGTTTACAGGAGC60 °C3470.01
3430.02
3390.10
3350.19
3310.19
3270.32
3230.12
3190.04

DS2CATTO12q11.2 (Chr2: 100654172-1006544369 Mb)ACAAAACTTAGCCGGGCATGGCAATGAACCATCACAGTCAGGG62 °C2720.04
2680.27
2640.39
2600.11
2560.06
2520.02
2480.03
2440.09
Figure 1

Cytogenetic localization of 2p11.2-q11.2 markers for Primary Open Angle Glaucoma locus GLC1B [Stoilova and Fujita ]. The known markers in the region flanked by D2S2161 and D2S176 (D2S417, D2S2264, D2S1897) and generated in this work D2SCATTO3, D2SCATTO4, D2SCATTO2 and D2SCATTO1) are shown. The ruler the partial map of chromosome 2 shows the relative nucleotide position expressed in Megabases (80 Mb-110 Mb, The University of California at Santa Cruz Genome Browser Gateway).

These markers can be used not only for screening families with POAG populations (Wolfs ), but also in other genetic studies in region 2p11.2-q11.2 where loci for different diseases mapped. Examples are Amish Infantile Epilepsy Syndrome (MIM: 609056), Chronic Obstructive Pulmonary Disease with Severe Early-Onset (MIM: 606963), Achromatopsia 2 (MIM: 216900) and Ahnidrotic Ectodermal Dysplasia (MIM: 224900). The study of other diseases mapped the overlapping region such as Schizophrenia (MIM: 181500), Congenital Cataract (MIM: 607304), Combined Deficiency of Vitamin K-Dependent Clotting Factors (MIM: 277450), Ataxia-Telangiectasia (MIM: 208900), Congenital Pulmonary Alveolar Proteinosis (MIM: 178640) Nephronophthisis (MIM: 256100) could also benefit from the use of these markers.
  3 in total

1.  Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study.

Authors:  R C Wolfs; P H Borger; R S Ramrattan; C C Klaver; C A Hulsman; A Hofman; J R Vingerling; R A Hitchings; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

Review 2.  Glaucoma genetics: advancing new understandings of glaucoma pathogenesis.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2004

3.  Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region.

Authors:  D Stoilova; A Child; O C Trifan; R P Crick; R L Coakes; M Sarfarazi
Journal:  Genomics       Date:  1996-08-15       Impact factor: 5.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.